As the Canadian market navigates through trade uncertainty and inflation concerns, investors are keenly observing how newly announced tariffs might impact economic growth. Amidst this backdrop, penny ...
Chemists designed the compound, known as VIP36, to bind cannabinoid receptor 1 (CB1) in the body but not in the brain. This design prevents the molecule from having psychoactive side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback